W. Dooley

Most-cited papers

1. Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy

   P. Whitworth, P. Beitsch, M. Murray, P. Richards +19 more

   2022JCO Precision Oncology4 citations Open access

   Semantic Scholar

   Save

2. Phase 1/2 study of STA-4783, a novel heat shock protein 70 (hsp70) inducer, in combination with paclitaxel in patients with soft tissue sarcomas (STS)

   M. Sherman, C. Ryan, M. Blackstein, D. Mendelson +4 more

   20054 citations

   Semantic Scholar

   Save

3. A phase 1, dose-escalation trial of STA-5312, a microtubule inhibitor with a novel binding site, in advanced or metastatic solid malignancies.

   A. Desai, M. Ratain, K. Moshier, M. Tipton +5 more

   2006Journal of Clinical Oncology2 citations

   Semantic Scholar

   Save

4. Abstract P3-19-12: Impact of endocrine therapy (ET) noncompliance following intra-operative radiation therapy (IORT) in treatment of early-stage breast cancer patients (pts) enrolled in the ExBRT trial

   B. Schwartzberg, A. Syed, R. Cohen, W. Dooley +3 more

   2022Cancer Research0 citations

   Semantic Scholar

   Save

5. Target for Invasive Breast Cancer Migration Inhibitory Factor Is a Therapeutic an Hla-presented Fragment of Macrophage

   J. Neethling, Othon Almanza, W. Dooley, William Aleksandar Mojsilovic +9 more

   0 citations

   Semantic Scholar

   Save